Objective To collect available evidence on management of large vessel vasculitis to inform
the 2018 update of the EULAR management recommendations. Methods Two independent …

Background Since the publication of the European League Against Rheumatism (EULAR)
recommendations for the management of large vessel vasculitis (LVV) in 2009, several …

Abstract Background Takayasu's Arteritis (TAK) affects mostly young women and causes
significant morbidity. Most patients are refractory to glucocorticoids (GC) or relapse when GC …

Introduction We conducted a systematic review of patient-reported outcome measures
(PROMs) regarding quality of life, disability, mood abnormalities (anxiety, depression) …

Takayasu arteritis (TAK) is a rare, chronic large-vessel vasculitis (LVV) that predominantly
affects aorta, its major branches and the pulmonary arteries. Recent advances in the …

Objective. Among the challenges in conducting clinical trials in large-vessel vasculitis (LVV),
including both giant cell arteritis (GCA) and Takayasu arteritis (TA), is the lack of …

Objective To assess the relationship between measures of disease assessment in patients
with large vessel vasculitis. Methods Patients with giant cell arteritis (GCA) or Takayasu …

Objective To provide a critical review of autoimmune encephalopathy—broadly defined as
neuropsychiatric features directly related to an autoimmune process—relevant for …

Systemic vasculitis encompasses a group of multisystem disorders; both the diseases and
the treatment strategies can have a significant impact on a patient's health-related quality of …

Takayasu arteritis (TA) is a debilitating, systemic disease that involves the aorta and large
arteries in a chronic inflammatory process that leads to vessel stenosis. Initially, the disease …